However, it has also been reported that ISG15 is upregulated by irinotecan treatment in colorectal cancer (CRC) cells, accompanied by the co-elevation of multiple resistance factors (e.g., osteopontin, survivin) [76]. This evidence concerns the gene ISG15 and colorectal carcinoma.